Corporate
India
A generics partner for what comes next
From everyday therapies to complex, high-barrier medicines, we are committed to making essential treatments more accessible, more reliable, and more sustainable.
Weʼre not just delivering generics, weʼre helping define the affordable medicines category. Weʼre broadening access across complex formulations by taking on high-barrier products others may not (or cannot) – because in an era of skyrocketing healthcare costs, every dose we deliver can impact peopleʼs lives.
20+ year
legacy in generics
We’ve built a generics engine that is fast and durable. It is focused on complex formulations across nearly all dosage forms and designed to outpace supply chain disruptions, cost pressures, and regulatory shifts so patients and partners can depend on us over the long term.
We use the breadth of our capabilities to combine scale with precision, optimizing production, streamlining processes, and responding quickly to customer and market needs. Our operations are built to deliver high-quality products when and where they are needed, even in the face of supply chain challenges.
We create value for the entire healthcare system by launching first-to-market generics that help make care more sustainable and more affordable for patients everywhere.
Our portfolio now includes more than 270 generic medicines, many of which represent difficult-to-manufacture or high-barrier-to-entry products, including categories such as oncologics, anti-infectives, and supportive care.
Andy Boyer
EVP, Chief Commercial Officer – Generics & Biosimilars
Quality is an absolute. We maintain our promise to patients through a strong FDA track record and high-performing U.S. and international facilities that are designed to meet rigorous global standards.
We work to optimize every step of the medicine supply chain, from sourcing to shipping. Our goal is simple: keep high-quality, affordable medicines within reach for our partners and the patients they serve.
There is no one-size-fits-all approach. We collaborate with agility and flexibility, developing the innovative solutions and building relationships that last.
Our generics portfolio spans key therapeutic areas and complex formulation types — designed to improve access and support sustainable care across the healthcare system.
Epinephrine Auto-injector
Taking Control Over It Campaign
Naloxone HCl Nasal Spray
Exenatide Injection
Reliable, widely prescribed therapies delivered with precision and consistency across high-volume categories.
Critical hospital and specialty medicines produced through advanced sterile manufacturing to ensure safety and availability.
High-quality ophthalmic formulations developed for performance, sterility, and stability.
Complex respiratory therapies produced through structured development pathways and rigorous quality systems.
Dermatologic and systemic products designed for targeted delivery and ease of use.
Innovative formulations and device-based generics that expand access to critical emergency and chronic therapies.
From everyday therapies to complex, high-barrier medicines, we are committed to making essential treatments more accessible, more reliable, and more sustainable.
